High degree of efficacy in the treatment of cyclic vomiting syndrome with combined co-enzyme Q10, L-carnitine and amitriptyline, a case series
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cyclic vomiting syndrome (CVS), defined by recurrent stereotypical episodes of nausea and vomiting, is a relatively-common disabling and historically difficult-to-treat condition associated with migraine headache and mitochondrial dysfunction. Limited data suggests that the anti-migraine therapies amitriptyline and cyproheptadine, and the mitochondrial-targeted cofactors co-enzyme Q10 and L-carnitine, have efficacy in episode prophylaxis. METHODS: A retrospective chart review of 42 patients seen by one clinician that met established CVS diagnostic criteria revealed 30 cases with available outcome data. Participants were treated on a loose protocol consisting of fasting avoidance, co-enzyme Q10 and L-carnitine, with the addition of amitriptyline (or cyproheptadine in those < 5 years) in refractory cases. Blood level monitoring of the therapeutic agents featured prominently in management. RESULTS: Vomiting episodes resolved in 23 cases, and improved by > 75% and > 50% in three and one additional case respectively. Among the three treatment failures, two could not tolerate amitriptyline (as was also the case in the child with only > 50% efficacy) and one had multiple congenital gastrointestinal anomalies. Excluding the latter case, substantial efficacy (> 75% response) was 26/29 at the start of treatment, and 26/26 in those able to tolerate the regiment, including high dosages of amitriptyline. CONCLUSION: Our data suggest that a protocol consisting of mitochondrial-targeted cofactors (co-enzyme Q10 and L-carnitine) plus amitriptyline (or possibly cyproheptadine in preschoolers) coupled with blood level monitoring is highly effective in the prevention of vomiting episodes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“There were fourteen studies that included 600 adult and pediatric patients.”
From Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) · cites this paper as [23]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Across these studies, 413/600 (70%) of patients reported complete or partial improvement with a decrease in frequency, duration, or severity of CVS symptoms when treated with a TCA, most commonly amitriptyline.”
From Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) · cites this paper as [23]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rome III: New standard for functional gastrointestinal disorders.
Drossman, D. A., & Dumitrascu, D. L. (2006) · PubMed · Cited by 660
Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial
Sándor, P. S., Di Clemente, L., Coppola, G., Saenger, U., Fumal, A., Magis, D., Seidel, L., Agosti, R. M., & Schoenen, J. (2005) · Neurology · doi:10.1212/01.wnl.0000151975.03598.ed · Cited by 371 · cited 1×
“In migraine, a randomized control trial demonstrated therapeutic efficacy [7].”
BackgroundA modern approach to the treatment of mitochondrial disease
The Mitochondrial Medicine Society, Parikh, S., Saneto, R., Falk, M. J., Anselm, I., Cohen, B. H., & Haas, R. (2009) · Current Treatment Options in Neurology · doi:10.1007/s11940-009-0046-0 · Cited by 348
Li, B. U., Lefevre, F., Chelimsky, G. G., Boles, R. G., Nelson, S. P., Lewis, D. W., Linder, S. L., Issenman, R. M., & Rudolph, C. D. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318173ed39 · Cited by 290
Self-citationCyclic vomiting syndrome in adults
Abell, T. L., Adams, K. A., Boles, R. G., Bousvaros, A., Chong, S. K. F., Fleisher, D. R., Hasler, W. L., Hyman, P. E., Issenman, R. M., Li, B. U. K., et al. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01113.x · Cited by 194 · cited 1×
“Clinical [11] and molecular [12] data suggest that CVS in adults, in particular with the adult onset of vomiting”
BackgroundSelf-citationIs cyclic vomiting syndrome related to migraine?
Li, B. U. K., Murray, R. D., Heitlinger, L. A., Robbins, J. L., & Hayes, J. R. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70242-8 · Cited by 185 · cited 1×
“Although the etiology is unknown, substantial parallels with migraine headache [4] have prompted therapeutic trials with anti-migraine therapies.”
BackgroundCyclical Vomiting Syndrome in Children: A Population‐Based Study
Abu‐Arafeh, I., & Russell, G. (1995) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1995.tb11966.x · Cited by 179 · cited 1×
“CVS is likely common, being present in about 2% of Scottish [2] and Western Australian [3] school children.”
BackgroundTreatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study
Boles, R. G., Lovett-Barr, M. R., Preston, A., Li, B. U., & Adams, K. (2010) · BMC Neurology · doi:10.1186/1471-2377-10-10 · Cited by 91 · cited 1×
“A recent subject recallbased study in CVS suggested equivalent efficacy of coenzyme Q10 and amitriptyline (~70%), but with superior tolerability of co-enzyme Q10 [5].”
BackgroundSelf-citationTHE PERIODIC SYNDROME: ITS NATURE AND PREVALENCE
Cullen, K. J., & Macdonald, W. B. (1963) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1963.tb24739.x · Cited by 85 · cited 1×
“CVS is likely common, being present in about 2% of Scottish [2] and Western Australian [3] school children.”
BackgroundBoles, R. G., Zaki, E. A., Lavenbarg, T., Hejazi, R., Foran, P., Freeborn, J., Trilokekar, S., & Mccallum, R. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01305.x · Cited by 75 · cited 1×
“Clinical [11] and molecular [12] data suggest that CVS in adults, in particular with the adult onset of vomiting episodes [12] is distinct in many ways than CVS in children.”
BackgroundSelf-citation
Cited by
Frye, R. E., Rose, S., Slattery, J., & MacFabe, D. F. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.27458 · Cited by 142
Venkatesan, T., Levinthal, D. J., Tarbell, S. E., Jaradeh, S. S., Hasler, W. L., Issenman, R. M., Adams, K. A., Sarosiek, I., Stave, C. D., Sharaf, R. N., et al. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13604 · Cited by 137
Managing cyclic vomiting syndrome in children: beyond the guidelines
Li, B. U. K. (2018) · European Journal of Pediatrics · doi:10.1007/s00431-018-3218-7 · Cited by 88
Bhandari, S., & Venkatesan, T. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4432-7 · Cited by 79
“There have been previous studies on CVS using the ICD-9-CMcode for the diagnosis, albeit few [9, 10].”
ResultCyclic Vomiting Syndrome in Children
Raucci, U., Borrelli, O., Nardo, G. D., Tambucci, R., Pavone, P., Salvatore, S., Baldassarre, M. E., Cordelli, D. M., Falsaperla, R., Felici, E., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.583425 · Cited by 80
“Using frequent or longer-lasting energy sources (protein bars) and coenzyme Q10 (10 mg/kg/day), can improve stamina and participation in school and extracurricular activities (53).”
Background
Metadata
- Authors
- Boles, R. G.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Boles, Richard G
- ORCID
- Boles, Richard G
- Venue
- BMC Neurology
- Published
- 2011-08-16
- Volume
- 11
- Issue
- 1
- Pages
- 102-102
- ISSN
- 1471-2377 (ISSN-L)
- PMC
- PMC3163531
- OpenAlex
- W2080157592
- Cited by
- 73
- References
- 13
- Citations by year
- 2025: 5 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 9 · 2020: 1 · 2019: 5 · 2018: 8 · 2017: 6 · 2016: 7 · 2015: 8 · 2014: 10 · 2013: 3 · 2012: 3
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Neurology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- cyclic vomiting syndrome, coenzyme Q10, L-carnitine, amitriptyline, cyproheptadine, mitochondrial dysfunction, migraine, blood level monitoring, refractory vomiting, congenital gastrointestinal anomaly
- MeSH terms
- Adolescent, Adult, Amitriptyline, Carnitine, Child, Child, Preschool, Diet Therapy, Female, Humans, Male, Retrospective Studies, Ubiquinone, Vitamins, Vomiting, Adrenergic Uptake Inhibitors, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High degree of efficacy in the treatment of cyclic vomiting syndrome with combined co-enzyme Q10, L-carnitine and amitriptyline, a case series. https://app.cochat.ai/papers/10.1186/1471-2377-11-102
- The paper
- Boles, R. G. (2011). High degree of efficacy in the treatment of cyclic vomiting syndrome with combined co-enzyme Q10, L-carnitine and amitriptyline, a case series. BMC Neurology. https://doi.org/10.1186/1471-2377-11-102
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.